Blood marker may reveal hidden inflammation in arthritis patients
NCT ID NCT07648836
First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study will measure a protein called IL-41 in the blood of 90 people with ankylosing spondylitis or psoriatic arthritis, plus healthy volunteers. Researchers want to see if higher levels of this protein are linked to more active disease. The goal is to find a simple blood test that could help doctors track inflammation and disease activity in these chronic conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could point toward a new way to measure disease activity in these conditions using a simple blood test.
- What could go wrong
- This is a small, early observational study, so results may not apply to all patients. It only looks at a marker, not a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Can a new gel calm psoriasis Flare-Ups?
- Can a Once-Daily cream tame psoriasis in toddlers?
- Could a simple protein test unlock the secrets of joint disease?
- Can a new injection calm psoriatic arthritis?
- Can a switch to guselkumab clear stubborn psoriasis?